KR20050102954A - A composition for probiotic functions comprising mixed live microorganims, yeast cultured composition and mixed enzymes as active ingredients - Google Patents

A composition for probiotic functions comprising mixed live microorganims, yeast cultured composition and mixed enzymes as active ingredients Download PDF

Info

Publication number
KR20050102954A
KR20050102954A KR1020040028294A KR20040028294A KR20050102954A KR 20050102954 A KR20050102954 A KR 20050102954A KR 1020040028294 A KR1020040028294 A KR 1020040028294A KR 20040028294 A KR20040028294 A KR 20040028294A KR 20050102954 A KR20050102954 A KR 20050102954A
Authority
KR
South Korea
Prior art keywords
composition
feed
mixed
probiotic
fermentation
Prior art date
Application number
KR1020040028294A
Other languages
Korean (ko)
Inventor
조성용
오태광
Original Assignee
주식회사 유니바이오테크
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 주식회사 유니바이오테크 filed Critical 주식회사 유니바이오테크
Priority to KR1020040028294A priority Critical patent/KR20050102954A/en
Publication of KR20050102954A publication Critical patent/KR20050102954A/en

Links

Classifications

    • EFIXED CONSTRUCTIONS
    • E06DOORS, WINDOWS, SHUTTERS, OR ROLLER BLINDS IN GENERAL; LADDERS
    • E06BFIXED OR MOVABLE CLOSURES FOR OPENINGS IN BUILDINGS, VEHICLES, FENCES OR LIKE ENCLOSURES IN GENERAL, e.g. DOORS, WINDOWS, BLINDS, GATES
    • E06B9/00Screening or protective devices for wall or similar openings, with or without operating or securing mechanisms; Closures of similar construction
    • E06B9/56Operating, guiding or securing devices or arrangements for roll-type closures; Spring drums; Tape drums; Counterweighting arrangements therefor
    • E06B9/80Safety measures against dropping or unauthorised opening; Braking or immobilising devices; Devices for limiting unrolling
    • EFIXED CONSTRUCTIONS
    • E06DOORS, WINDOWS, SHUTTERS, OR ROLLER BLINDS IN GENERAL; LADDERS
    • E06BFIXED OR MOVABLE CLOSURES FOR OPENINGS IN BUILDINGS, VEHICLES, FENCES OR LIKE ENCLOSURES IN GENERAL, e.g. DOORS, WINDOWS, BLINDS, GATES
    • E06B9/00Screening or protective devices for wall or similar openings, with or without operating or securing mechanisms; Closures of similar construction
    • E06B9/02Shutters, movable grilles, or other safety closing devices, e.g. against burglary
    • E06B9/08Roll-type closures
    • E06B9/11Roller shutters
    • E06B9/17Parts or details of roller shutters, e.g. suspension devices, shutter boxes, wicket doors, ventilation openings
    • E06B9/171Rollers therefor; Fastening roller shutters to rollers
    • EFIXED CONSTRUCTIONS
    • E06DOORS, WINDOWS, SHUTTERS, OR ROLLER BLINDS IN GENERAL; LADDERS
    • E06BFIXED OR MOVABLE CLOSURES FOR OPENINGS IN BUILDINGS, VEHICLES, FENCES OR LIKE ENCLOSURES IN GENERAL, e.g. DOORS, WINDOWS, BLINDS, GATES
    • E06B9/00Screening or protective devices for wall or similar openings, with or without operating or securing mechanisms; Closures of similar construction
    • E06B9/56Operating, guiding or securing devices or arrangements for roll-type closures; Spring drums; Tape drums; Counterweighting arrangements therefor
    • E06B9/58Guiding devices
    • E06B9/581Means to prevent or induce disengagement of shutter from side rails

Abstract

본 발명은 동물용 사료첨가용 복합생균제, 효모배양물 및 복합 효소제를 유효성분으로 함유하는 생리활성 조성물에 관한 것으로 동물용 사료에 첨가하여 가축의 사료섭취량 증진, 증체량 및 사료 이용률을 개선시키고 장내 세균총의 변화에 따른 정장효과와 설사예방 효과를 기대할 수 있다.The present invention relates to a physiologically active composition comprising an animal feed additive complex probiotic, a yeast culture and a complex enzyme as an active ingredient, which is added to an animal feed to improve feed intake, increase weight gain and feed utilization of livestock, and intestinal bacteria You can expect a formal effect and diarrhea prevention effect according to the change of.

Description

프로바이오틱 기능을 가지는 복합생균제, 효모 배양물 및 복합 효소제를 유효성분으로 함유하는 조성물{A composition for probiotic functions comprising mixed live microorganims, yeast cultured composition and mixed enzymes as active ingredients}A composition for probiotic functions comprising mixed live microorganims, yeast cultured composition and mixed enzymes as active ingredients

본 발명은 사료첨가용 복합생균제, 효모배양물 및 복합 효소제를 유효성분으로 함유하는 가축 성장 촉진용 조성물에 관한 것이다. 본 발명의 조성물은 동물용 사료에 첨가하여 그에 따른 기호성 향상과 사료섭취량 증가, 일당증체량 개선, 사료이용율 개선 등의 효과와 프로바이오틱(Probiotics) 효과가 있는 조성물이다. The present invention relates to a composition for promoting livestock growth containing a complex probiotic, yeast culture, and a complex enzyme for feed additives as an active ingredient. The composition of the present invention is a composition having the effects of improving the palatability and feed intake, increase the daily weight gain, improve feed utilization and the probiotics effect added to the animal feed.

오래 전부터 축산업에서는 가축질병 예방 및 생산성 증대를 목적으로 각종 첨가제를 사료에 첨가하여 가축에 급여하여 왔다. 그러나 이러한 첨가제중 항생·항균제를 비롯하여 인위적으로 조제된 여러 종류의 화학물질들은 계속된 사용으로 인하여 내성을 지닌 다수의 병원성 미생물들이 출현하였고, 고기와 우유에 잔류되어 인체에 악영향을 초래하는 등의 부작용이 발생하였다. 대중들의 건강에 관한 관심이 커지고 이러한 부작용들이 알려지면서 항생제나 화학적인 처리를 한 사료 및 축산물에 대한 좋지 않은 인식이 널리 퍼지게 되었으며, 유럽에서는 인체에 사용되고 있는 항생제는 가축의 성장촉진제로 사용할 수 없도록 규제하는 상태에 이르렀다. 최근에는 소비자의 요구 이외에 인체용 의약품과 교차 내성에 따른 내성균의 출현으로 국제적으로 사용가능한 항생제의 종류 및 잔류량 규제가 엄격해지고 있다. 현재, 전 세계적으로 이러한 추세가 계속 퍼져가고 있으며 앞으로는 성장촉진제용 항생제나 항균제 사용이 더욱 엄격한 규제를 받게 될 것이다. 이에 따라 최근 항생제의 단점을 보완한 대체 첨가제가 관심을 받고 있으며 친환경적인 제품들로 급속하게 대체되어가고 있다. 대표적인 것으로는 생균제(Probiotics), 효소(Enzyme), 및 효모배양물(Yeast culture)등과 이로부터 추출한 특정 면역활성물질(특정올리고당, 만난올리고당, 글루칸 등) 등의 자연첨가제(Natural additives)가 각광을 받고 있다.For a long time, the livestock industry has been supplying various additives to feed for the purpose of preventing livestock diseases and increasing productivity. However, many kinds of artificially prepared chemicals, including antibiotics and antibacterial agents, have appeared to be resistant to many pathogenic microorganisms due to their continued use, and they remain in meat and milk, causing adverse effects on the human body. This occurred. The growing public's concern about health and the recognition of these side effects have led to widespread perception of antibiotics and chemically processed feeds and livestock products. In Europe, antibiotics used in humans are not allowed to be used as animal growth promoters. I came to a state. Recently, in addition to consumer demand, the emergence of resistant drugs due to human drugs and cross-resistance, has led to strict regulations on the types and residues of antibiotics available internationally. At present, this trend continues to spread throughout the world, and in the future, the use of antibiotics or antimicrobials for growth promoters will be more stringent. Accordingly, the replacement additives that supplement the shortcomings of antibiotics have recently been attracting attention and are rapidly being replaced by eco-friendly products. Representatives include natural additives such as probiotics, enzymes, yeast cultures, and certain immunoactive substances extracted from them (specific oligosaccharides, met oligosaccharides, glucans, etc.). I am getting it.

생균제(probiotic)라는 용어는 Lilly 와 Stillwell(Lilly D. M. et al., Science, 'Probiotics: growth promoting factors produced by microorganism', 147; 747, 1996)에 의해서 최초로 사용되었으며, 살아있는 미생물 제제를 의미한다. Parker(Parker R. B., An Nutr & Health, 29; 4-8, 1974)는 생균제에 대해 '장내 미생물 균형에 영향을 주는 살아있는 미생물을 의미'하는 것으로 정의한 바 있다.The term probiotic was first used by Lilly and Stillwell (Lilly D. M. et al., Science, 'Probiotics: growth promoting factors produced by microorganism', 147; 747, 1996) and refers to living microbial agents. Parker (Parker R. B., An Nutr & Health, 29; 4-8, 1974) defined probiotics as 'living microorganisms that affect intestinal microbial balance'.

생균제는 장내 균총이 잘 발달되게 함으로써 'Nurmi concept'라고 불리는 경쟁적 배제의 개념으로 장내 유익한 미생물 군집이 성숙하게 하는 결과 그 후에는 살모넬라와 같은 병원성 미생물의 근접을 막을 수 있고(Nurmi E. et al., Nature, 241; 210, 1973), 장내에서 비타민이나 여러 효소 및 영양소를 생산하고, 숙주가 소화하지 못한 영양분을 분해하여 숙주에게 공급하여 가축의 증체율과 사료요구율을 개선하는데 유용하다.    Probiotics allow the intestinal flora to be well developed, leading to the maturation of beneficial microbial communities in the gut with the concept of competitive exclusion, called the 'Nurmi concept', which can subsequently prevent the proximity of pathogenic microorganisms such as Salmonella (Nurmi E. et al. , Nature, 241; 210, 1973), produce vitamins, enzymes and nutrients in the intestine, and break down nutrients that the host has not digested and feed them to the host to improve livestock growth and feed demand.

실제로 Tortuero는 Lactobacillus acidophilus를 배양하여 육계에 급여한 결과 맹장과 대장내의 균총에 영향을 준다고 보고하였고(Tortuero F., Poultry Sci. 52; 197-203, 1973), 한 등은 육계에 Lactobacillus sporogenes를 급여하였을 때 coliforms 등의 유해균의 수가 감소하였다고 보고하였다(한인규 등, 한국축산학회지, 26(2); 150-157, 1984). 김 등은 곰팡이 슨 옥수수에 Bacillus subtilis, Aspergillus oryzae 등의 복합생균제를 사용한 경우 coliforms 등의 유해균의 수가 감소했다고 보고하였다(김창종 등, 한국축산학회지, 30(9); 542-548, 1988). 또한, 생균제는 급성 로타바이러스성 설사(rotavirus diarrhea), 음식에 대한 알러지(food allergy) 및 결장암 등의 질병으로 생기는 비정상적인 장내균총을 치료하는데 사용된다고 보고된 바 있다(Salminen S. et al., Antonie Van Leeuwenhoek, 70(2-4);347-358, 1996).  In fact, Tortuero reported that cultivation of Lactobacillus acidophilus in broilers affects the flora of the caecum and colon (Tortuero F., Poultry Sci. 52; 197-203, 1973), and Han et al. It was reported that the number of harmful bacteria such as coliforms was decreased (In-Kyu et al., Korean Journal of Animal Science, 26 (2); 150-157, 1984). Kim et al. Reported that the use of complex probiotics such as Bacillus subtilis and Aspergillus oryzae decreased the number of harmful bacteria, such as coliforms, in fungal corn (Kim Chang-jong et al., 30 (9); 542-548, 1988). Probiotics have also been reported to be used to treat abnormal gut flora caused by diseases such as acute rotavirus diarrhea, food allergy and colon cancer (Salminen S. et al., Antonie). Van Leeuwenhoek, 70 (2-4); 347-358, 1996).

육계에 있어서 생균제의 이용은 Tortuero(1973)에 의하여 처음으로 시작되었다. 이에 따르면 Lactobacillus acidophilus를 배양하여 육계에 급여한 결과 증체율의 개선을 확인하였다. 그 후 Lactobacillus spp.를 배양하여 육계에 급여한 실험들을 통하여 가축의 성장이 유도되었음이 보고되었다(Burkett 1977 Dilworth 1978 Watkins 1996 Mohan 1996 Yeo 1997 Jin 1998).   The use of probiotics in broilers was first initiated by Tortuero (1973). According to this study, Lactobacillus acidophilus was cultured and fed to broiler chickens. Subsequently, it was reported that livestock growth was induced through experiments in which Lactobacillus spp. Was cultured and fed to broilers (Burkett 1977 Dilworth 1978 Watkins 1996 Mohan 1996 Yeo 1997 Jin 1998).

Aspergillus oryzae는 생육 pH와 온도범위가 매우 넓은 호기성 곰팡이로 다양한 유기성 폐자원을 기질로 이용할 수 있으며(Garraway, Evans, 1984), 생성하는 효소는 amylase, xylanase 및 protease등으로 이들 효소가 기질의 이용성을 증가시킴으로서 사료적 가치를 향상시키고(Petterson등, 1989), 동물 체내에서 생성되는 내열성 효소의 작용을 보충하여 영양소의 소화 및 체내 흡수를 용이하게 한다(Graham등, 1988) 또한 균체 단백질 함량이 30-60%정도로 riboflavin, folic acid 및 nicotinic acid등 다양한 비타민을 합성할 뿐만 아니라 발효과정에서 생성된 미지 성장인자(Unknown Growth Factor; U.G.F.) 공급원으로서 가축의 성장을 촉진하는 것으로 알려져 있다.(Russo와 Lfeimann, 1959; Tsang과 Schaible 1960)  Aspergillus oryzae is an aerobic fungus with a very wide growth pH and temperature range and can use various organic waste resources as substrates (Garraway, Evans, 1984). The enzymes produced are amylase, xylanase and protease. Increasing the feed value (Petterson et al., 1989) and supplementing the action of heat-resistant enzymes produced in the animal body to facilitate the digestion and absorption of nutrients (Graham et al., 1988). In addition to synthesizing various vitamins such as riboflavin, folic acid and nicotinic acid to about 60%, it is known to promote livestock growth as an unknown growth factor (UGF) source produced during fermentation (Russo and Lfeimann, 1959; Tsang and Schaible 1960)

곰팡이와 효모배양물의 사료 첨가는 반추위내 미생물 군집의 변화(Wiedmeier등 1987; Frumholtz등, 1989; Fondevila 등, 1990), VFA의 생성량과 그 비율의 변화(Wiedmeier등, 1987), 사료섭취량의 증가(Kellems 등, 1990), 소화율과 사료이용율의 개선(Wiedmeier등 1987; Fondevila 등, 1990) 산유량과 증체량 향상(Kellems등 1990)등의 효과를 나타냄으로써 가축의 생산성을 향상시키는 것으로 보고되었다. Feeding of fungi and yeast cultures was associated with changes in the rumen microbial community (Wiedmeier et al. 1987; Frumholtz et al., 1989; Fondevila et al., 1990), VFA production and its proportions (Wiedmeier et al., 1987) Kellems et al., 1990), and improved digestibility and feed utilization (Wiedmeier et al. 1987; Fondevila et al., 1990) have been reported to improve livestock productivity by improving production and weight gain (Kellems et al. 1990).

그러나, 실제로 생균제를 사료첨가제로 사용하는 데에는 몇가지 어려움이 있는데 예를 들면 Lactobacillus를 사료첨가제로 이용하기 위해서 어린 자돈에 급여하는 경우 유당(lactose)이 함유된 처리구에서만 증체량의 개선효과가 보여졌음이 보고된 바 있고(Pollman 1980), 또한, Lactobacillus 균주는 장내 효소에 대한 내구성과 위산에 대한 내산성에 있어서 한계를 보이는데, 이는 물론 물리적인 가공처리로 해결할 수도 있겠으나 경제성을 고려한다면 그다지 바람직하지 못하다고 할 수 있다. 더불어 가공사료 생산시 요구되는 내열성에 있어서도 한계가 있는데, 이러한 한계를 극복하기 위해서는 포자형성균인 B. subtilis 또는 B. coagulans(L. sporegenes)가 사용되기도 하였다.   However, there are some difficulties in the use of probiotics as feed additives. For example, when Lactobacillus is fed to young piglets for use as feed additives, it has been reported that the improvement of weight gain was shown only in the treatment containing lactose. (Pollman 1980), Lactobacillus strains also have limitations in the resistance to intestinal enzymes and acid resistance to gastric acid, which can of course be solved by physical processing, but not so desirable considering economics. have. In addition, there are limitations in the heat resistance required for the production of processed feed. To overcome this limitation, spore forming bacteria such as B. subtilis or B. coagulans (L. sporegenes) have been used.

이에 B. coagulans(L. sporegenes)을 육계에 급여하여 증체율의 개선 및 coliforms 등의 유해균의 수가 감소되었다는 보고가 있었으며(한 등, 1984), B. subtilis를 육계에 급여하여 사료효율의 개선 뿐만 아니라 간과 혈청내의 콜레스테롤 함량이 감소되었다는 보고가 있었다(Santoso, 1995). 또한, 쥐에 B. subtilis를 급여하여 분내 Lactobacillus spp.에 영향을 줌을 확인하였으며, L. murinus 와 B. subtilis를 함께 체외에서 배양시 L. murinus의 성장이 증가되었음으로 확인하고 보고함으로써 B. subtilis가 유산균의 성장에 영향을 미칠 가능성을 제시한 바 있다(Hosoi, 1999).There was a report that feeding B. coagulans (L. sporegenes) to broilers improved the weight gain and reduced the number of harmful bacteria such as coliforms (Han et al., 1984). There have been reports of decreased cholesterol content in liver and serum (Santoso, 1995). In addition, rats were fed B. subtilis to affect Lactobacillus spp. In the rats. L. murinus and B. subtilis were cultured together in vitro to increase the growth of L. murinus. Subtilis has been suggested to affect the growth of lactic acid bacteria (Hosoi, 1999).

그러나, 상기 내생포자 형성균 또한 여러 가지 한계를 가지고 있는데, 그 하나는 바로 생균제조시 제조공정상의 문제로 얼마나 많은 내생포자 형성균이 내성포자를 형성하는가 하는 점에서의 한계이며, 두 번째는 형성된 포자가 위를 통과한 후 소장에 도달한 뒤 얼마나 빠르게 포자를 벗고 장관내에 부착될 수 있는가하는 점에서의 한계이다.However, the endogenous spore forming bacteria also have a number of limitations, one of which is a limitation in how many endogenous spore forming bacteria form resistant spores due to problems in the manufacturing process during probiotic production, and the second is formed spores. This is a limitation in how quickly the spores can be removed and attached to the intestine after reaching the small intestine after passing through scissors.

본 발명자들은 상기와 같은 종래 생균제들이 갖는 한계를 극복하고, 본래의 장점을 극대화시켜 상승효과(synergy effect)를 가져올 수 있도록 가축에게 부족하기 쉬운 영양소를 공급하고, 사료이용률을 개선시키며 장내 세균총을 안정화시켜 병원성 미생물에 의한 질병을 예방하고, 생리활성 물질을 분비하여 가축의 면역성을 증진할 수 있는 사료첨가제로서 효과적인 복합생균제, 효모 배양물 및 복합 효소제를 유효성분으로 함유하는 조성물을 개발하였다.The present inventors overcome the limitations of the conventional probiotics as described above, supply nutrients that are easily lacking, improve feed utilization and stabilize the intestinal bacterial flora so as to maximize the original advantages and bring about a synergy effect (synergy effect). In order to prevent diseases caused by pathogenic microorganisms, and to increase the immunity of livestock by secreting physiologically active substances, a composition containing an effective complex probiotic, yeast culture and complex enzyme as an active ingredient was developed.

본 발명의 목적은 각각의 생균제 및 효모, 효소제의 장점을 극대화 하고 단점을 보완하여 미지성장인자를 비롯한 부족하기 쉬운 영양소를 공급하고 사료이용성을 개선시키며 장내 세균총의 안정화를 통한 병원성 미생물에 의한 질병을 예방하고 첨가된 생리활성 물질 및 생균이 분비하는 생리활성 물질로 인한 면역성을 증진시키는 효과적인 사료첨가제로서 유용한 복합생균제, 효모 배양물 및, 복합 효소제를 유효성분으로 함유하는 조성물을 제공하는 데 그 목적이 있다. The purpose of the present invention is to maximize the advantages of each probiotic, yeast, enzyme and supplement the shortcomings to supply nutrients, such as unknown growth factors, insufficient nutrients, improve feed availability and disease caused by pathogenic microorganisms through stabilization of the intestinal flora The purpose of the present invention is to provide a composite probiotic, a yeast culture, and a composition containing a complex enzyme as an active ingredient, which are useful as an effective feed additive for preventing and adding immunity due to the added bioactive substance and the bioactive substance secreted by live bacteria. have.

상기 본 발명의 목적을 달성하기 위하여 복합 생균제 10~30%(중량), 효모배양물 5~20%(중량) 및 복합 효소제(“Enzyme cocktail”이라고도 한다.) 0.1~1.0%(중량)를 혼합하여 가축 생장촉진용 조성물을 제조한다.In order to achieve the object of the present invention, 10 to 30% (by weight) of complex probiotic, 5 to 20% (by weight) of yeast culture, and 0.1 to 1.0% (by weight) of complex enzyme (also called “Enzyme cocktail”) are mixed. To prepare a composition for promoting livestock growth.

이하는 본 발명을 구체적으로 기술한다.(이하 퍼센트는 중량%를 의미한다.)The following describes the present invention specifically. (Hereinafter, percentage means weight%.)

본 발명에 첨가되는 1)복합생균제의 발효배지는 한약재 약 10-30%, 해조류 및 수산부산물 약 10-15%, 산야초 약 5-10%, 게껍질 약 2-5%, 어분 약 2-5%, 쌀겨 약 10-25%, 깻묵 약 3-7%, 곡물피 가루 약 13-17%, 질석, 제올라이트 및 맥반석에서 선택된 광물질 약 5-9%, 황토 약 1-3%으로 구성되며 이 발효 배지에 바실러스 서브틸리스(Bacillus subtilis), 바실러스 써린지엔시스(Bacillus thuringiensis), 유산균, 광합성세균(시아노박테리아(Cyanobacteria) 등), 효모균, 그람양성의 방선균(스트렙토마이세스(Streptomyces spp.)) 및 곰팡이균(아스퍼질러스 오리지(Aspergillus oryzae), 아스퍼질러스(Aspergillus spp.), 페니실리움(Penicillum) 등) 등의 복합 미생물을 사용하여 호기발효, 혐기발효, 숙성 발효의 과정을 거쳐 생산되었으며, 이 조성물내 함유된 총균주의 수는 1g 당 광합성 세균 2종(4 × 105), 효모 6종(6.2 × 106), 곰팡이 3종(1.1 × 106), 단백질 분해균 4종(2 × 104), 지방 분해균(6.5 × 106)이다.Fermentation medium of 1) complex biocide added to the present invention is about 10-30% of herbal medicines, about 10-15% of seaweeds and aquatic by-products, about 5-10% of wild vegetables, about 2-5% of crab shells, about 2-5 of fishmeal %, Rice bran about 10-25%, ink about 3-7%, grain skin about 13-17%, minerals selected from vermiculite, zeolite and elvan, about 5-9%, ocher about 1-3%. Bacillus subtilis, Bacillus thuringiensis, lactic acid bacteria, photosynthetic bacteria (Cyanobacteria, etc.), yeast, gram-positive actinomycetes (Streptomyces spp.) In the medium And aerobic fermentation, anaerobic fermentation, and ripening fermentation using complex microorganisms such as fungi (Aspergillus oryzae, Aspergillus spp., Penicillium, etc.). The total number of strains contained in the composition was 2 photosynthetic bacteria (4 × 10 5 ), 6 yeasts ( 6.2 × 10 6 ), three fungi (1.1 × 10 6 ), four proteolytic bacteria (2 × 10 4 ), and lipolytic bacteria (6.5 × 10 6 ).

본 발명에서 사용되는 한약재로서는 당귀, 감초, 천궁, 작약, 신선초, 황기에서 선택된 한약재 1종 또는 2종이상을 사용할 수 있다.   Herbal medicines used in the present invention can be used one or two or more of the herbs selected from Angelica, Licorice, Cheongung, Peony, Sinchocho, Astragalus.

본 발명에서 사용되는 해조류 및 수산부산물로서는 우뭇가사리, 해태, 미역, 다시마에서 선택된 1종 또는 2종이상의 성분을 사용할 수 있다.  As the algae and marine by-products used in the present invention, one or two or more components selected from Locust larvae, Haitai, seaweed and kelp can be used.

본 발명에서 사용될 수 있는 산야초로서는 명아주, 모싯대, 사철쑥, 도라지, 둥글래에서 선택된 1종 또는 2종이상의 산야초를 사용할 수 있다.   As the wild grass that can be used in the present invention, one or two or more kinds of wild grass selected from Myungju, Mosquito, Saejanggye, bellflower, and round can be used.

본 발명에서 사용되는 곡물피로는 대두씨, 면실피, 옥피에서 선택된 1종이상을 사용할 수 있다.   As the grain hides used in the present invention, one or more selected from soybean seed, cotton thread, and oxpi may be used.

배양은 1) 한약재 약 10-30%, 해조류 및 수산부산물 약 10-15%, 산야초 약 5-10%, 게껍질 약 2-5%, 어분 약 2-5%, 쌀겨 약 10-25%, 깻묵 약 3-7%, 곡물피 가루 약 13-17%, 질석, 제올라이트 및 맥반석에서 선택된 광물질 약 5-9%, 황토 약 1-3%를 혼합한 발효배지를 회전드럼 발효기에 넣고 미생물을 접종한 후,    Cultivation: 1) about 10-30% of herbal medicines, about 10-15% of seaweeds and marine by-products, about 5-10% of wild grasses, about 2-5% of crab shells, about 2-5% of fishmeal, about 10-25% of rice bran, Put fermentation broth mixed with about 3-7% ink, about 13-17% grain powder, about 5-9% minerals selected from vermiculite, zeolite and elvan, and about 1-3% ocher. After

2) 저온, 중온 및 고온으로 10 내지 12시간 동안 호기발효시킨 후,   2) after aerobic fermentation at low, medium and high temperature for 10 to 12 hours,

3) 얻어진 발효산물을 혐기 단열발효통으로 옮겨서 혐기상태에서 발효시킨 다음,   3) The obtained fermented product is transferred to an anaerobic adiabatic fermentation vessel and fermented in anaerobic state,

4) 발효산물을 액체 저반 발효기로 옮겨 저온, 중온 및 고온을 20 내지 30일간의 숙성 발효과정을 거쳐 복합 생균제제를 제조한다.   4) The fermentation product is transferred to a liquid bottom fermenter to produce a composite probiotic through a fermentation process of 20 to 30 days at low, medium and high temperatures.

상기 2단계의 호기 발효는 상온에서 시작하여 공기를 주입하면서 가열하여 점차적으로 온도를 높여가며 발효를 진행시키는 것으로서, 저온발효는 상온에서 50℃까지의 온도에서 2 내지 3시간 동안 발효시키는 것이며, 중온발효는 50 내지 70℃의 온도까지의 조건에서 2 내지 3시간 동안 발효시키는 것이고, 고온발효는 70 내지 80℃의 온도조건으로 1 내지 2시간 동안 발효시킨다.   The aerobic fermentation of the second step is to proceed with fermentation gradually increasing the temperature by heating while injecting air, starting at room temperature, low temperature fermentation is to ferment for 2 to 3 hours at a temperature from room temperature to 50 ℃, medium temperature Fermentation is a fermentation for 2 to 3 hours at a temperature of 50 to 70 ℃, high temperature fermentation is fermented for 1 to 2 hours at a temperature of 70 to 80 ℃.

상기 3)단계의 혐기발효에서는 35 내지 45℃의 조건으로 6 내지 8일동안 발효시킨다.   In the anaerobic fermentation of step 3) it is fermented for 6 to 8 days under the condition of 35 to 45 ℃.

상기 4)단계의 숙성발효는 순수 발효열에 의한 95±3℃의 온도조건이 유지되는 상태에서 pH 3.3±0.2의 조건으로 20 내지 30일간 혐기발효시킨다.   The fermentation fermentation of step 4) is anaerobic fermentation for 20 to 30 days under the condition of pH 3.3 ± 0.2 under the condition that the temperature of 95 ± 3 ℃ by pure fermentation heat is maintained.

상기 4)의 숙성발효 산물은 탈수기에서 자연탈수 방법으로 5 내지 7일동안 고액분리하여 액체는 안정조에서 보관되었다가 식물재배용 비료 또는 양액의 첨가제로서 이용이 가능하며, 분리된 고형물은 동물 사육용 첨가제로서 사용된다.   The fermentation product of 4) is solid-liquid separated for 5 to 7 days by a natural dehydration method in a dehydrator, and the liquid is stored in a stable tank and can be used as an additive for plant cultivation fertilizer or nutrient solution, and the separated solid is used for animal breeding. Used as an additive.

본 발명에서 사용되는 복합 생균제는 이 고형물을 이용한다. (이 복합생균제는 특허출원번호 제 2000-44427호로 현재 특허출원 계류중에 있다.)   The complex probiotic used in the present invention utilizes this solid. (This combination probiotic is pending patent application under patent application number 2000-44427.)

본 발명에서 사용되는 2)효모배양물(이스트컬춰 Yeast culture)은 분리된 사카로마이세스 세레비시아에(Saccharomyces cerevisiae)를 옥수수 시럽, 가수분해한 옥수수가루, 효모추출물, 카세인, 미량광물질, 비타민 B그룹을 포함하는 비타민 프리믹스(vitamin premix)와 전분, 모노포타슘 포스페이트(mono potassium phosphate), 포타슘 디-포스페이트 potassium di-phosphate)와 맥아당으로 구성된 발효 배지에 배양하여 순수 배양된 바실러스 서브틸리스(bacillus subtilis)와 바실리스 리케니포미스(Bacillus licheniformis)의 균체와 배양물을 첨가하여 생산한다. 이 제품은 kg당 Saccharomyces cerevisiae 5.0×1012 CFU, Bacillus subtilis 와 Bacillus licheniformis 가 1.5×1010CFU이상을 포함한다.2) Yeast culture used in the present invention (Yeast culture) is isolated saccharomyces cerevisiae (Saccharomyces cerevisiae) corn syrup, hydrolyzed corn flour, yeast extract, casein, trace minerals, vitamins Bacillus subtilis (Bacillus subtilis) cultured in a fermentation medium consisting of vitamin premix including star B, starch, mono potassium phosphate, potassium di-phosphate and potassium maltose subtilis) and Bacillus licheniformis cells and cultures are added. It contains Saccharomyces cerevisiae 5.0 × 10 12 CFU / kg and Bacillus subtilis and Bacillus licheniformis 1.5 × 10 10 CFU / kg.

이 효모 추출물은 시판중이며 이를 구입하여 사용할 수도 있으며, 효모를 배양하여 사용할 수도 있다.  This yeast extract is commercially available and can be purchased and used, or can be cultured and used.

본 발명에서 사용되는 3)Enzyme cocktail은 g당 아밀라제 22,000FIP, 프로타제 1,600 FIP, 리파제 28,000 FIP 이상을 포함한다. 본 발명에서 사용되는 아밀라제, 프로테아제 및 리파제는 현재 시판중이며, 시판중인 효소제를 사용한다.  3) Enzyme cocktail used in the present invention contains more than 22,000 FIP amylase, 1,600 FIPase, lipase 28,000 FIP per g. Amylases, proteases and lipases used in the present invention are commercially available and use commercially available enzymes.

본 발명의 조성물은 동물사육용 기초사료 대비 0.05 내지 0.5중량%, 바람직하게는 0.1 내지 0.3중량%를 사용한다.   The composition of the present invention uses 0.05 to 0.5% by weight, preferably 0.1 to 0.3% by weight relative to the basic feed for animal breeding.

다음에 실시예 및 시험예로서 본 발명을 더욱 상세히 설명한다.  Next, the present invention will be described in more detail as examples and test examples.

실시예 1Example 1

성장 촉진용 복합 생균, 효모, 복합 효소제 조성물의 제조Preparation of complex probiotic, yeast and complex enzyme composition for growth promotion

시판중인 효모배양물 5~20%, 복합 생균제(특허출원 제 2000-44427호로 현재 특허출원 계류중에 있으며, 이 출원인으로부터 구입하여 사용함) 10~30% 을 혼합하고, 여기에 Enzyme cocktail 0.1~1.0%를 혼합하여 제조하였다.   Commercially available yeast culture 5-20%, complex probiotics (patent pending 2000-44427, pending patent application, purchased from the applicant) 10-30% mixed, Enzyme cocktail 0.1 ~ 1.0% It was prepared by mixing.

실험예 1 Experimental Example 1

육계의 증체량에 미치는 효과Effect on weight gain in broilers

육계의 기초사료에 본 발명의 조성물 0.1%를 첨가하여 혼합한 다음 통상의 사료의 급이와 같이 40일간 급이하고 평균 증체량(g), 평균 사료 섭취량(g), 사료 요구율 및 장내 대장균 수(CFU)를 본 발명의 조성물을 첨가하지 아니한 사료를 급이한 대조구와 비교실험을 행하였다. 그 결과는 다음의 표 1과 같았다.0.1% of the composition of the present invention is added to broiler broiler feed, followed by 40 days of feeding, and the average weight gain (g), the average feed intake (g), the feed requirement and the number of enteric coliforms ( CFU) was compared with the control group fed the feed without addition of the composition of the present invention. The results were as shown in Table 1 below.

표 1: 육계의 증체량에 미치는 효과Table 1: Effect on weight gain in broilers

상기 표 1에서 확인되는 바와 같이 본 발명의 조성물은 비첨가 대조군에 비하여 평균 증체량(g), 평균 사료 섭취량(g), 사료 요구율 및 장내 대장균 수(CFU)에서 월등한 효과를 나타내었다.As confirmed in Table 1, the composition of the present invention showed an excellent effect on the average weight gain (g), average feed intake (g), feed requirement and enteric coliform count (CFU) compared to the non-added control group.

실험예 2 Experimental Example 2

이유자돈의 증체 및 폐사율에 미치는 영향Effect of Weaning Pig Growth and Mortality

이유 자돈의 기초사료에 본 발명의 조성물 0.1%, 표모배양물 0.1%첨가, 및 비투여 대조구로 구분하고, 다음 통상의 사료의 급이와 같이 63일간 급이하고 개시 체중(kg), 종료체중(kg) 일당 증체량(g), 일당 사료 섭취량(g) 및 사료 요구율을 각각 측정하였다. 그 결과를 다음의 표 2에 나타내었다.Weaned piglets were divided into 0.1% of the composition of the present invention, 0.1% added to the head culture, and non-administered controls, and fed for 63 days and fed with the starting weight (kg) and the end weight as in the following normal feed. (kg) Weight gain per day (g), feed intake per day (g) and feed demand were measured respectively. The results are shown in Table 2 below.

표 2: 이유자돈의 증체 및 폐사율에 미치는 영향Table 2: Effect on weight gain and mortality of weaning piglets

상기 표 2에에서 확인되는 바와 같이 본 발명의 조성물은 비첨가 대조구 및 효모배양물 투여군에 비하여 에 비하여 종료체중(kg), 일당 증체량, 일당 사료섭치량 및 사료요구율에서 월등한 효과를 나타내었다.As confirmed in Table 2, the composition of the present invention showed an excellent effect on the end weight (kg), daily gain, daily feed intake and feed rate compared to the non-added control and yeast culture administration group.

상기한 바와 같이 본 발명의 조성물은 사료에 첨가하여 가축에 급여함으로써 가축의 사료 섭취량을 증가 시키고 사료 이용성을 개선시키며 여러생리활성 물질들로 인하여 장내 세균총의 안정화 및 질병억제 효과를 얻을 수 있다.As described above, the composition of the present invention can be added to feed to feed livestock to increase feed intake of livestock, improve feed availability, and stabilize the intestinal bacterial flora and disease suppression due to various physiologically active substances.

Claims (2)

프로바이오틱 기능이 있는 복합생균제, 효모배양물 및 복합 효소제를 유효성분으로 함유하는 가축 성장촉진용 조성물.Livestock growth promoting composition comprising a probiotic complex probiotic, yeast culture and complex enzyme as an active ingredient. 제 1항에 있어서, 복합생균제 10~30(중량)%, 효모배양물 5~20%(중량) 및 복합 효소제 0.1~1.0%(중량)를 유효성분으로 함유하는 가축 성장촉진용 조성물.The composition for promoting animal growth according to claim 1, comprising 10 to 30% by weight of complex probiotic, 5 to 20% by weight of yeast culture, and 0.1 to 1.0% by weight of complex enzyme.
KR1020040028294A 2004-04-23 2004-04-23 A composition for probiotic functions comprising mixed live microorganims, yeast cultured composition and mixed enzymes as active ingredients KR20050102954A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020040028294A KR20050102954A (en) 2004-04-23 2004-04-23 A composition for probiotic functions comprising mixed live microorganims, yeast cultured composition and mixed enzymes as active ingredients

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020040028294A KR20050102954A (en) 2004-04-23 2004-04-23 A composition for probiotic functions comprising mixed live microorganims, yeast cultured composition and mixed enzymes as active ingredients

Publications (1)

Publication Number Publication Date
KR20050102954A true KR20050102954A (en) 2005-10-27

Family

ID=37281021

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020040028294A KR20050102954A (en) 2004-04-23 2004-04-23 A composition for probiotic functions comprising mixed live microorganims, yeast cultured composition and mixed enzymes as active ingredients

Country Status (1)

Country Link
KR (1) KR20050102954A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100836091B1 (en) * 2007-08-28 2008-06-09 효성오앤비 주식회사 Microelement complex fertilizer containing organic mineral
WO2009064035A1 (en) * 2007-11-12 2009-05-22 Serombio Co., Ltd Growth-enhancing yeast hydrolysate and health food comprising the same

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100287825B1 (en) * 1999-05-15 2001-04-16 이태일 Probiotics For Feed Additives
KR20020065368A (en) * 2001-02-05 2002-08-13 누트리노바 누트리티온 스페치알티스 운트 포트 인그레딘츠 게엠베하 Sorbic acid product comprising probiotics as addition to feedstuffs in agricultural livestock rearing
KR20020087571A (en) * 2001-05-14 2002-11-23 주식회사 인섹트 바이오텍 Compositions for forage additive comprising protease
KR100418016B1 (en) * 2000-07-31 2004-02-11 (주)엠에스토피아 Microorganism composition using as probiotics for growth promoting nutrient

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100287825B1 (en) * 1999-05-15 2001-04-16 이태일 Probiotics For Feed Additives
KR100418016B1 (en) * 2000-07-31 2004-02-11 (주)엠에스토피아 Microorganism composition using as probiotics for growth promoting nutrient
KR20020065368A (en) * 2001-02-05 2002-08-13 누트리노바 누트리티온 스페치알티스 운트 포트 인그레딘츠 게엠베하 Sorbic acid product comprising probiotics as addition to feedstuffs in agricultural livestock rearing
KR20020087571A (en) * 2001-05-14 2002-11-23 주식회사 인섹트 바이오텍 Compositions for forage additive comprising protease

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100836091B1 (en) * 2007-08-28 2008-06-09 효성오앤비 주식회사 Microelement complex fertilizer containing organic mineral
WO2009064035A1 (en) * 2007-11-12 2009-05-22 Serombio Co., Ltd Growth-enhancing yeast hydrolysate and health food comprising the same
CN101888783B (en) * 2007-11-12 2014-09-03 赛瑞欧生物有限公司 Growth-enhancing yeast hydrolysate and health food comprising the same

Similar Documents

Publication Publication Date Title
Elisashvili et al. Recent advances in the physiology of spore formation for Bacillus probiotic production
JP5872104B2 (en) New Bacillus subtilis {NOVELBACILLUSSUBTILIS}
US20170042949A1 (en) System and method for production of shelf stable probiotics for animal nutrition enhancement
CN110122658A (en) A kind of fermentative feedstuff of microbe and its preparation method and application
CN103110033A (en) Pig feed additive and preparation method thereof
CN102422996B (en) Preliminary microbial fermentation antibiotic-free feed for growth fattening pigs
CN103125778A (en) Poultry feed additive and preparation method thereof
CN101186896A (en) Fermentation material for composite microorganism and preparation method thereof
CN1997387A (en) Methods and compositions for improving growth of meat-type poultry
CN105166422A (en) Biological fermentation feed for accelerating pig growth and preparation method thereof
CN110214871A (en) A kind of layer breeding probiotics and preparation method thereof
CN102524535A (en) Oligopeptide additive for feed and preparation method thereof
CN108835444A (en) Kind goose feed, preparation method, application and fowl food
CN104886392A (en) Biological fermentation pig feed replacing antibiotics, and preparation method of biological fermentation pig feed
CN107006690A (en) A kind of feed addictive containing active Chinese drug component probiotics
CN109722392B (en) Culture medium capable of promoting bacillus subtilis to produce spores and application thereof
CN104886391A (en) Biological fermentation feed for reducing odor of pig manure and preparation method of biological fermentation feed
KR20160143499A (en) A fermented feedstuff additive composition having enhanced active components by bioconversion using microorganisms and the method for preparing of the same
CN105325738A (en) Feed additive special for pet dog
CN113414226A (en) Kitchen waste leavening agent and preparation method and application thereof
CN102106487B (en) Biological fermentation feed for laying chickens and production method
KR20030075996A (en) Feed additives using Bacillus subtilis and Saccharomyces cerevisiae, and a method of manufacture thereof
KR101034467B1 (en) Microorganism cultivating medium containing enzymatic hydrolysate of wheat bran and konjak
CN110419622B (en) Composite probiotic oligosaccharide fruit feed additive and preparation and use methods thereof
CN112825980A (en) Method for producing glucose oxidase functional active peptide powder for livestock and aquatic products based on microbial fermentation

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E601 Decision to refuse application